DCM
ICUI icon

Defilade Capital Management’s ICU Medical ICUI Stock Holding History

Defilade Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Sell
105,700
-148,591
-58% -$19.4M 2.07% 19
2026
Q1 		$32.8M Sell
254,291
-86,454
-25% -$12.4M 4.61% 6
2025
Q4 		$48.6M Buy
+340,745
New +$45.6M 6.59% 4

Other funds holding ICUI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Defilade Capital Management's ICUI Position: Q2 2026 in Review

Defilade Capital Management reduced its ICU Medical (ICUI) stake by 58% in Q2 2026, selling an estimated $19.4M and leaving 105,700 shares worth $15.5M. The position accounts for 2.07% of the portfolio, ranked #19.

Defilade Capital Management first reported a position in ICUI in Q4 2025 and has held it in 3 quarters since. The position peaked at $48.6M in Q4 2025. 288 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Defilade Capital Management held 105,700 shares of ICU Medical worth $15.5M as of Q2 2026.
  • Defilade Capital Management sold 148,591 ICU Medical shares in Q2 2026, an estimated $19.4M.
  • ICU Medical made up 2.07% of Defilade Capital Management's portfolio in Q2 2026, its #19 holding.
  • Defilade Capital Management first reported a position in ICU Medical in Q4 2025 and has held it in 3 quarters since.
  • Defilade Capital Management's ICU Medical position peaked at $48.6M in Q4 2025.
  • 288 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Defilade Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.